High-dose-rate Interstitial Brachytherapy with Computed Tomography-based Treatment Planning for Patients with Locally Advanced Uterine Cervical Carcinoma

  • SAITOH Jun-ichi
    Department of Radiation Oncology, Gunma University Graduate School of Medicine
  • OHNO Tatsuya
    Department of Radiation Oncology, Gunma University Graduate School of Medicine
  • SAKURAI Hideyuki
    Department of Radiation Oncology, Gunma University Graduate School of Medicine Department of Radiation Oncology, University of Tsukuba
  • KATOH Hiroyuki
    Department of Radiation Oncology, Gunma University Graduate School of Medicine
  • WAKATSUKI Masaru
    Department of Radiation Oncology, Gunma University Graduate School of Medicine
  • NODA Shin-ei
    Department of Radiation Oncology, Gunma University Graduate School of Medicine
  • SUZUKI Yoshiyuki
    Department of Radiation Oncology, Gunma University Graduate School of Medicine
  • SIBUYA Kei
    Department of Radiation Oncology, Gunma University Graduate School of Medicine
  • TAKAHASHI Takeo
    Department of Radiation Oncology, Gunma University Graduate School of Medicine
  • NAKANO Takashi
    Department of Radiation Oncology, Gunma University Graduate School of Medicine

この論文をさがす

抄録

The aims of this study were to carry out a dose volume analysis of high-dose-rate interstitial brachytherapy with computed tomography-based treatment planning and to investigate the treatment outcome of patients with locally advanced bulky and/or irregularly shaped uterine cervical carcinoma. Between July 2003 and December 2007, 15 patients were treated with external beam radiation therapy and high-dose-rate interstitial brachytherapy with or without intracavitary brachytherapy. Seven patients were treated with interstitial brachytherapy alone, and 8 were treated with combined use of intracavitary and interstitial brachytherapy. A comparison of the volume and dose parameters with intracavitary and interstitial brachytherapy in patients who received both treatments showed that the median D90 of the high-risk clinical target volume per fraction was 4.4 Gy with intracavitary brachytherapy and 5.6 Gy with interstitial brachytherapy, and the median V100 was 66% with intracavitary brachytherapy and 85% with interstitial brachytherapy. The median D2cc of the bladder with intracavitary and interstitial brachytherapy per fraction was 5.5 Gy and 4.7 Gy, respectively, and the median D2cc of the rectum with intracavitary and interstitial brachytherapy was 5.9 Gy and 4.1 Gy, respectively. The median follow-up time was 37 months, and the overall and progression-free survival rates for all patients at 3 years were 78% and 51%, respectively. The actuarial 2-year and 3-year locoregional control rates were 80% and 71%, respectively. Dose distribution was improved with image-based interstitial brachytherapy, and satisfactory local control was achieved for patients with locally advanced uterine cervical carcinoma in which intracavitary brachytherapy may result in a suboptimal dose distribution.

収録刊行物

被引用文献 (5)*注記

もっと見る

参考文献 (42)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ